2016-03-13T00:00:00.000-05:00
Buy rating,0.356961
rhythm management business,-0.674317
price target,0.337871
longer term outlook,0.581956
Consumer business,0.287522
DexCom shares,0.298389
Outperform rating,0.519353
Piper Jaffray analyst,0.223853
Intuitive Surgical,0.306794
newly launched Darzalex,0.359151
analyst,-0.00956342
Medical Device space,0.27001
St. Jude,-0.674317
share price,0.392965
analyst Larry Biegelsen,-0.674317
revenue growth,0.27615
St. Jude Medical,-0.674317
key existing drugs,-0.355026
Intuitive Surgical shares,0.389736
new products,0.212678
Cowen analyst Doug,-0.266207
DexCom management,-0.389429
average topline growth,0.480237
Johnson,0.318801
CHANGE Target,-0.465617
company,-0.0242716
upcoming generic competition,-0.355026
Bank analyst Kristen,-0.24984
basic sum-of-the-parts analysis,0.366401
